Fig 1.
[Aneuploid Cohort: Clinical + Research specimens] composition of specimens included in the Aneuploid Cohort.
C = Clinical specimens; R = Research specimens.
Fig 2.
[Y Cohort: Clinical + Research specimens] composition of specimens included in the Y Cohort.
C = Clinical specimens; R = Research specimens.
Table 1.
[Aneuploid Cohort: Clinical + Research specimens] comparison of aneuploid chromosome mosaicism ratio among affected singletons, two affected twins, and one affected twin, by aneuploidy.
Table 2.
[Aneuploid Cohort: Clinical + Research specimens] distribution of aneuploid MR by trisomy.
Table 3.
[Y Cohort: Clinical + Research specimens] comparison of Y chromosome mosaicism ratio between XX/XY and XY/XY twins in euploid, aneuploid, and combined cases.
Table 4.
[Y Cohort: Clinical + Research specimens] probability of XX/XY versus XY/XY outcome based on Y MR when Y chromosome material is detected.
Includes only euploid cases.
Table 5.
Accuracy of twin fetal sex prediction (XX/XY vs. XY/XY outcome when Y material is detected) in euploid gestations at various Y MR cutoffs.
Analysis based on Y MRs from 98 euploid samples.
Table 6.
[Y Cohort: Clinical + Research specimens] probability of XX/XY versus XY/XY outcome based on Y MR when Y chromosome material is detected.
Includes euploid and aneuploid cases.
Table 7.
[Aneuploid Cohort: Clinical specimens] triplet cases with positive cfDNA results and outcome information.
Table 8.
[Y Cohort: Research specimens] cfDNA and diagnostic information for triplet and quadruplet research specimens.